Clinical trial
Paclitaxel With or Without Carboplatin in Treating Patients With Advanced…
NCT00003117 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00003117 |
|---|---|
| Title | Paclitaxel With or Without Carboplatin in Treating Patients With Advanced Non-small Cell Lung Cancer |
| Official title | Single-Agent Versus Combination Chemotherapy in Advanced NSCLC: A CALGB Randomized Trial of Efficacy, Quality of Life, and Cost-Effectiveness |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug |
| Interventions | carboplatin, paclitaxel |
| Enrollment | 584 |
| Start date | Oct 1, 1997 |
| Primary completion | Dec 1, 2004 |
| Completion | Jan 1, 2006 |
| First posted | May 19, 2004 |
| Last update posted | Jun 30, 2016 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: